|
|
Stock Notice | August 2026
|
|
New Product · Starting Strength In Stock
Foundayo® ▼ (orforglipron)
0.8mg Now In Stock at Primed
Eli Lilly’s once-daily oral GLP-1 receptor agonist has arrived. The 0.8mg starting strength is in stock and available to order today. Higher strengths will follow — we will confirm dates as soon as we have them.
|
|
0.8mg
In Stock Now
|
Next Day
Delivery
|
Once Daily
Oral Tablet
|
|
|
Foundayo® is Eli Lilly’s orforglipron — a once-daily oral GLP-1 receptor agonist for weight management, with the UK the first country to grant approval. Primed is holding the 0.8mg starting strength now, so patients can be initiated straight away. Supply of the higher strengths is being released in stages by the manufacturer, and we will write to you with confirmed dates.
|
| Product Summary |
| Medicine |
Foundayo® ▼ (orforglipron) tablets |
| Manufacturer |
Eli Lilly and Company |
| Presentation |
Once-daily oral tablet. Six strengths licensed in the UK: 0.8mg, 2.5mg, 5.5mg, 9mg, 14.5mg and 17.2mg. |
| Licensed Indication |
Weight management in adults. Refer to the current Foundayo® SmPC for the full licensed indication, patient selection criteria, dosing and titration schedule. |
| Available Now |
0.8mg — in stock
Refer to the current SmPC for full prescribing, administration and storage information.
|
| To Follow |
2.5mg
5.5mg
9mg
14.5mg
17.2mg
Availability dates to be confirmed. We will notify partner clinics directly as each strength becomes available.
|
|
What This Means for Your Clinic
|
|
You can initiate patients now
0.8mg is the starting strength, so suitable patients can begin treatment immediately. Please factor the staged release of higher strengths into your titration planning.
|
|
|
A further oral option for patients who decline injectables
Needle-free treatment widens the group of patients you can realistically start and keep on therapy.
|
|
|
Simpler handling than injectables
A tablet presentation removes the sharps-disposal considerations that come with pens.
|
|
|
Dispensed by a GPhC-registered, WDA-licensed pharmacy
Sourced through licensed UK supply channels, with full traceability on every pack dispensed.
|
|
For Pricing and Ordering Details
Contact the Primed account team for current pricing on 0.8mg, to register interest in the higher strengths, or to add Foundayo® to your existing formulary.
|
|
|
Not yet a Primed partner?
Join the clinics already dispensing through Primed
We are a GPhC-registered, MHRA WDA-licensed dispensing pharmacy working with regulated UK private clinics.
| Named-patient dispensing across weight management, ADHD, TRT, HRT and aesthetics |
| Validated cold-chain fulfilment |
| Controlled drug dispensing, Schedule 2–5 |
| API and clinic portal integration |
| Dedicated B2B account management |
Register Your Clinic →
|
|
|
|
|
